GSK
762 hedge funds and large institutions have $9.69B invested in GSK in 2017 Q4 according to their latest regulatory filings, with 135 funds opening new positions, 168 increasing their positions, 348 reducing their positions, and 109 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $9.83B → $9.69B (-$147M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
52% less repeat investments, than reductions
Existing positions increased: 168 | Existing positions reduced: 348
Holders
762
Holding in Top 10
9
Calls
$107M
Puts
$99.7M
Top Buyers
| 1 | +$1.04B | |
| 2 | +$599M | |
| 3 | +$64.3M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$53.2M |
| 5 |
Millennium Management
New York
|
+$46.8M |
Top Sellers
| 1 | -$190M | |
| 2 | -$120M | |
| 3 | -$72M | |
| 4 |
MHI
Miller Howard Investments
Kingston,
New York
|
-$54.1M |
| 5 |
Morgan Stanley
New York
|
-$36.6M |